Disease Info Card

Congenital Small Ears

Information about Congenital Small Ears: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Congenital Small Ears

Most recent studies have shown that Congenital Small Ears shares some biological mechanisms with atresia, cicatrix, cleft-lip, cleft-palate, complete-hearing-loss, conductive-hearing-loss, congenital-abnormality, congenital-absence, congenital-absence-of-external-ear, congenital-ocular-coloboma-(disorder), dysplasia, ear-deformities-acquired, ear-diseases, facial-asymmetry, fetal-growth-retardation, goldenhar-syndrome-with-ipsilateral-radial-defect, hypoplasia, mandibulofacial-dysostosis, micrognathism, stenosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Congenital Small Ears, and have been seen in publications frequently: Aging, Blood Circulation, Cell Migration, Cell Proliferation, Dehiscence, Ear Development, Inner Ear Development, Limb Development, Mating, Meiosis Ii, Methylation, Neural Crest Cell Migration, Ossification, Pathogenesis, Pigmentation, Regeneration, Segmentation, Transport, Transposition, Wound Healing

Quite a number of genes have been found to play important roles in Congenital Small Ears, such as BMP5, CYLD, ELN, F11, FGF3, HES1, HMGCL, HOXA2, LIPC, NDUFB6, PRKRA, PTCRA, RBBP6, RPS19, SGPL1, SS18L1, TCOF1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.